Annual report pursuant to Section 13 and 15(d)

Consolidated Statements of Stockholders' Deficit

v3.22.2
Consolidated Statements of Stockholders' Deficit - USD ($)
Preferred Stock [Member]
Series A Preferred Stock [Member]
Preferred Stock [Member]
Series B Preferred Stock [Member]
Common Stock [Member]
Additional Paid-in Capital [Member]
Stock Payable [Member]
Retained Earnings [Member]
Noncontrolling Interest [Member]
Total
Beginning balance, value at Mar. 31, 2020 $ 500 $ 37,975 $ 43,533,242 $ (46,427,396) $ (82,101) $ (2,937,780)
Beginning balance, shares at Mar. 31, 2020 5,000,000 2,250 379,742,524          
Issuance of common stock upon conversion     $ 3,974 547,047       551,021
Issuance of common stock upon conversion, shares     39,735,626          
Reclass of derivative liability upon conversion or redemption of related convertible debentures       205,000       205,000
Purchase of Series B Preferred shares     3,250,000       3,250,000
Purchase of Series B Preferred shares, shares 3,250            
Beneficial conversion feature related to the Series B Preferred Shares       1,335,000   (1,335,000)  
Dividends payable on Series B PS           (317,085)   (317,085)
Series B PS Dividends in kind issued     134,442       134,442
Series B PS Dividends in kind issued, shares   115            
Conversion of Series B PS to common stock   $ 11,351 (11,351)      
Conversion of Series B PS to common stock, shares   (5,008) 113,517,030          
Common stock issued in Vista Warrant settlement     $ 1,750 608,250       610,000
Common stock issued in Vista Warrant settlement, shares     17,500,000          
Reclass of warrant liability upon the cancellation of warrants under Vista Warrant settlement       90,000       90,000
Common stock issued to consultants     $ 425 744,825       745,250
Common stock issued to consultants, shares     4,250,000          
Beneficial conversion feature related to the Series D Preferred Shares       6,050,000       6,050,000
Amortization of beneficial conversion feature related to Series D Preferred Shares           (1,720,833)   (1,720,833)
Accretion on Series D Preferred shares           (302,500)   (302,500)
Commitment shares issued with Series D Preferred Shares     $ 600 (600)      
Commitment shares issued with Series D Preferred Shares, shares     6,000,000          
Common stock to be issued as finder’s fees related to asset acquisition         136,000     136,000
Beneficial conversion feature related to convertible debenture       163,636       163,636
Net loss           (3,580,454) (5,729) (3,586,183)
Ending balance, value at Mar. 31, 2021 $ 500 $ 56,075 56,649,491 136,000 (53,683,268) (87,830) 3,070,968
Ending balance, shares at Mar. 31, 2021 5,000,000 607 560,745,180          
Issuance of common stock upon conversion     $ 133 421,353   421,486
Issuance of common stock upon conversion, shares     1,329,246          
Series B PS Dividends in kind issued   278,400     278,400
Series B PS Dividends in kind issued, shares 232            
Conversion of Series B PS to common stock   $ 1,007 (1,007)  
Conversion of Series B PS to common stock, shares   (839) 10,068,000          
Common stock issued to consultants     $ 48 158,285   158,333
Common stock issued to consultants, shares     476,946          
Net loss           (86,297,748)   (86,297,748)
Conversion of Series D PS to common stock     $ 43 (43)  
Conversion of Series D PS to common stock, shares     428,572          
Exchange of Series D PS to Series E PS     (3,258,189)   (3,258,189)
Sale of common shares and warrants for cash, less offering costs and commitment shares     $ 3,577 17,273,546   17,277,123
Sale of common shares and warrants for cash, less offering costs and commitment shares, shares     35,772,729          
Exercise of warrants related to the sale of common shares     $ 110 10,890   11,000
Exercise of warrants related to the sale of common shares, shares     1,100,000          
Beneficial conversion feature related to the Series E Preferred Shares     3,439,219   3,439,219
Amortization of beneficial conversion feature related to Series E Preferred Shares     (3,349,198)   (3,349,198)
Redemption of Series D Preferred shares     (2,534,758)   (2,534,758)
Common shares to be issued for the acquisition of the non-controlling interest subsidiary’s remaining equity     (3,087,830) 2,000,000 87,830 (1,000,000)
Common shares to be issued for Patent acquisition     5,000,000   5,000,000
Common stock vested to consultants     $ 47 221,424   221,472
Common stock vested to consultants, shares     412,500          
Common stock issued to employees     $ 18 82,954 24,600   107,572
Common stock issued to employees, shares     275,000          
Common shares to be issued for Technical Rights Agreement     4,762,376   4,762,376
Revision of dividends payable on Series B Preferred Shares (See Note 2)     (182,639)   (182,639)
Conversion of Series E PS to common stock     $ 822 2,879,179     2,880,001
Conversion of Series E PS to common stock, shares     8,228,572          
Dividends payable on Preferred Shares       (392,390)   (392,390)
Accretion of Series E Preferred Shares     (337,834)   (337,834)
Common shares issued for Technical Rights Agreement     $ 1,287 4,761,089 (4,762,376)  
Common shares issued for Technical Rights Agreement, shares     12,871,287          
Common shares issued for acquisition of non-controlling interest and Patent acquisition     $ 1,386 6,998,614 (7,000,000)    
Common shares issued for acquisition of non-controlling interest and Patent acquisition, shares     13,861,386          
Reclassification of warrants to liability     (2,935,000)   (2,935,000)
Common stock to be issued for legal settlement to NSH shareholders     29,388,000   29,388,000
Common stock issued for legal settlement to NSH shareholders     $ 2,889 9,413,060 (9,415,950)  
Common stock issued for legal settlement to NSH shareholders, shares     28,494,706          
Common stock issued for financing expense     $ 58 137,982   138,040
Common stock issued for financing expense, shares     580,000          
Ending balance, value at Mar. 31, 2022 $ 500 $ 67,500 $ 96,701,607 $ 20,132,650 $ (150,036,023) $ (33,133,766)
Ending balance, shares at Mar. 31, 2022 5,000,000 674,644,124